Mauritz Venter
CEO
Zwiegelaar Cobus
COO
Funding
A clean view of how AzarGen Biotechnologies has raised across 1 round, including Series B, who has backed it, and how the capital stack has evolved.
Total Raised
$3.1M
Latest Post-money
Latest Round
Series B
Announced
Jan 7, 2016
Money Raised
$3,100,000
Transaction Name
Lead investor
—
